89bio, Inc.
ETNB
$9.04
$0.273.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -157.83% | -134.30% | -158.16% | -128.33% | -47.18% |
| Total Depreciation and Amortization | -25.53% | -13.33% | -24.00% | -8.16% | -14.55% |
| Total Amortization of Deferred Charges | 70.32% | 37.58% | -4.92% | -44.48% | -29.96% |
| Total Other Non-Cash Items | 80.57% | 58.03% | 13.07% | 10.74% | -8.57% |
| Change in Net Operating Assets | -407.36% | -296.60% | -2,311.26% | 43.66% | -643.79% |
| Cash from Operations | -165.26% | -188.03% | -184.72% | -129.97% | -55.52% |
| Capital Expenditure | -2,075.00% | -2,075.00% | -275.00% | -100.00% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.38% | 115.11% | 66.79% | -76.51% | 48.71% |
| Cash from Investing | -33.48% | 115.07% | 66.78% | -76.51% | 48.70% |
| Total Debt Issued | -- | -- | -61.63% | -61.63% | -100.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 112.34% | 112.53% | -58.60% | -36.00% | -51.57% |
| Repurchase of Common Stock | 24.14% | 39.35% | -15.59% | -6.61% | -260.30% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.10% | 100.00% | -- | -- | -- |
| Cash from Financing | 119.01% | 119.52% | -57.40% | -34.31% | -52.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -150.25% | 173.35% | -172.86% | -189.41% | -117.98% |